The Post-COVID-19 syndrome: diagnostic criteria, mechanisms of pathogenesis and mucosal immune response
Literature review
DOI:
https://doi.org/10.11603/2311-9624.2023.4.14502Keywords:
COVID-19, post-COVID-19 syndrome, inflammatory diseases, oral mucosa, immune responses, cytokine stormAbstract
Summary. The COVID-19 pandemic is still in the spotlight of the world's scientific community today, as it has had an unprecedented impact on the world with its negative consequences. The potential routes of infection and the pathogenesis of COVID-19 remain unclear, so further studies could help in the prevention and treatment of coronavirus infection.
The aim of the study – to analyze data from scientific literature sources on the manifestations of post-COVID syndrome, mechanisms of pathogenesis of coronavirus infection, including the immune response of mucous membranes, in particular the oral mucosa, diagnostic methods using saliva as a promising diagnostic tool for COVID-19 in the dental practice.
Materials and Methods. The bibliosemantic method was used to clarify the state of the problem, and to study the analysis of the results of previous scientific research based on the sources of literature and electronic resources.
Results and Discussion. Today, it remains important to fully investigate and understand the immunological aspects of the long-term course of COVID-19, a phenomenon that occurs when people continue to experience a range of symptoms and consequences even after the acute phase of COVID-19 infection has been overcome. The post-COVID syndrome is a new phenomenon that is troubling both doctors and patients and is becoming an emerging global problem. The recurrent symptom pattern of the “long tail” of COVID-19-related diseases includes a range of complaints from different organs and systems, including changes in the state of oral health (teeth, gums, mucous membranes). Potential pathways of 2019-nCov infection on the oral mucosa have been reported, with ACE2 being expressed in the oral cavity, including epithelial cells, T cells, B cells, and fibroblasts. Among the different oral sites, ACE2 expression was found to be higher in the epithelial cells of the tongue than in the mucous membranes of the cheeks and gums. These findings provide a preliminary explanation for the underlying mechanism that makes the oral cavity a potentially high-risk zone for 2019-nCoV infection and provide evidence for future prevention strategies in dental clinical practice.
Conclusions. The results of the literature review showed that data on the clinical progression of COVID-19 after the acute phase is very limited, and little is known about the medium and long-term outcomes. Therefore, a multidisciplinary approach and the development and organization of comprehensive individual rehabilitation plans are extremely important and crucial in assessing the condition of patients with post-COVID syndrome.
References
COVID-19 Data Explorer. Retrieved from: https://ourworldindata.org/explorers/coronavirus-data-explorer.
Mohan, A., Iyer, V.A., Kumar D, Batra, L., & Dahiya, P. (2023). Navigating the Post-COVID-19 Immunological Era: Understanding Long COVID-19 and Immune Response. Life (Basel), 13(11), 2121. DOI: 10.3390/life13112121.
Stanford Medicine. Infectious Disease Division Guidance on Pharmacotherapeutics for COVID-19 Patients. 5/24/20. Retrieved from: https://med.stanford.edu/id/covid19.html.
COVID-19 rapid guideline: managing the long-term effects of COVID-19 (NG188): Evidence reviews 6 and 7: monitoring and referral. London: National Institute for Health and Care Excellence (NICE); 2020 Dec. (NICE Guideline, No. 188.). Retrieved from: https://www.ncbi.nlm.nih.gov/books/NBK567265/.
Bull-Otterson L, Baca, S., Saydah, S., Boehmer, T.K., Adjei, S., Gray, S., & Harris, A.M. (2022). Post-COVID conditions among adult COVID-19 survivors aged 18-64 and ≥ 65 years - United States, March 2020 - November 2021. Morbidity and Mortality Weekly Report.
DOI: 10.15585/mmwr.mm7121e1.
COVID-19 (coronavirus): Long-term effects (2022). Mayo Clinic. Retrieved from: https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351.
Long COVID or post-COVID conditions. Centers for Disease Control and Prevention (2022). Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects.html.
Post-COVID conditions: Overview for healthcare providers. Centers for Disease Control and Prevention (2022). Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.
Al-Aly, Z., Xie, Y., & Bowe, B. (2021). High-dimensional characterization of post-acute sequelae of COVID-19. Nature (en), 594(7862), 259-264.
DOI: 10.1038/s41586-021-03553-9.
Multisystem inflammatory syndrome (MIS). Centers for Disease Control and Prevention (2022). Retrieved from: https://www.cdc.gov/mis/index.html.
Saeed, S., Tadic, M., Larsen, T.H., Grassi, G., & Mancia G. (2021). Coronavirus disease 2019 and cardiovascular complications: focused clinical review. J. Hypertens., 39(7), 1282-1292. DOI: 10.1097/HJH.0000000000002819.
Covid-19: Prolonged and relapsing course of illness has implications for returning workers Comment and opinion from The BMJ's international community of readers, authors, and editors (2020). BMJ. Retrieved from: https://blogs.bmj.com/bmj/2020/06/23/covid-19-prolonged-and-relapsing-course-of-illness-has-implications-for-returning-workers/.
Patient tips: Healthcare provider appointments for post-COVID conditions (2022). Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/long-term-effects/post-covid-appointment/index.html.
Oliynyk, O., Barg, W., Dubrow, S., & Oliynyk, Y. (2022). Lack of Difference in Tocilizumab Efficacy in the Treatment of Severe COVID-19 Caused by Different SARS-CoV-2 Variants. J. Pers. Med., 12, 1103.
DOI: 10.3390/jpm12071103.
Yelin, D., Wirtheim, E., Vetter, P., Kalil, A.C., Bruchfeld, J., Runold, M., Guaraldi, G., & Mussini, C. (2020). Long-term consequences of COVID-19: research needs. The Lancet. Infectious Diseases, 20(10), 1115-1117.
DOI: 10.1016/S1473-3099(20)30701-5.
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B, Wu, H., … Tan, W. (2020). Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224), 565-574.
DOI: 10.1016/S0140-6736(20)30251-8.
Zhang, H., Kang, Z., Gong, H., Xu, D., Wang, J., Li, Z., … Xu, H. (2020). Digestive system is a potential route of COVID-19: an analysis of single-cell coexpression pattern of key proteins in viral entry process. Gut, 69(6), 10101018. DOI: 10.1136/gutjnl-2020-320953.
Zubachyk, V.M., & Riznyk, Yu.B. (2013). Patohenetychne znachennia dysfunktsii endoteliiu sudyn mikrotsyrkuliatornoho rusla parodontu u formuvanni ta perebihu heneralizovanoho parodontytu [Pathogenetic significance of the dysfunction of the endothelium of vessels of the periodontal microcirculatory bed in the formation and course of generalized periodontitis]. Sovremennaia stomatolohyia – Modern dentistry, 4(68), 50-53 [in Ukrainian].
Eyerich, K., Dimartino, V., & Cavani, A. (2017). IL-17 and IL-22 in immunity: Driving protection and pathology. Eu.r J. Immunol., 47(4), 607-614.
DOI: 10.1002/eji.201646723.
Bukhtyarova, T., Omelianenko, Z., Khomenko, V., & Yadlovskyi, O. (2010). Rol tsytokynovoho zvena v vospalytelnom protsesse [The role of the cytokine link in the inflammatory process]. Visnyk farmakolohii ta farmatsii – Herald of pharmacology and pharmacy 9, 22-25 [in Russian].
Denha, O.V., & Denha, E.M. (2009). Intehralna еkspres-otsinka rivnia funktsionalnykh reaktsii v porozhnyni rota u ditei [Integral express evaluation of the level of functional reactions in the oral cavity in children]. Visnyk stomatolohii – Journal of dentistry, 5, 130-148 [in Ukrainian].
Kriachok, I.A., Ulianchenko, K.O., & Kadnikova, T.V. (2017). MALT-lymfoma: prichiny vozniknovenyia, patogenez, klassifykatsyia, klinycheskaia kartyna [MALT-lymphoma: causes, pathogenesis, classification, clinical picture]. Klynycheskaia onkolohyia – Clinical oncology, 1(25), 33-36 [in Russian].
Hajishengallis, G. (2015). Periodontitis: from microbial immune subversion to systemic inflammation. Nat. Rev. Immunol. 15, 30-44.
Abaturov, O.Ye. (2015). Efektyvnist likuvannia respiratornykh virusnykh zakhvoriuvan u ditei iz vykorystanniam bakterialnykh lizativ [Effectiveness of treatment of respiratory viral diseases in children with the use of bacterial lysates]. Zdorove rebenka – Child's health, 1(60), 21-24 [in Ukrainian].
Gevkaliuk, N., Sydliaruk, N., Pynda, M., Pudiak, V., & Krupey, V. (2018). Condition of non-specific resistance of oral mucous membrane in children with viral influenza stomatitis in the concept of MALT-system. Georgian Med. News, 280-281, 34-40. PMID: 30204091.
Mark Welch, J.L., Rossetti, B.J., Rieken, C.W., Dewhirst, F.E., & Borisy, G.G. (2016). Biogeography of a human oral microbiome at the micron scale. Proc. Natl. Acad. Sci. U S A, 113(6), E791-800.
DOI: 10.1073/pnas.1522149113.
Ross, K.F., & Herzberg, M.C. (2016). Autonomous immunity in mucosal epithelial cells: fortifying the barrier against infection. Microbes. Infect.,18(6), 387-398.
DOI: 10.1016/j.micinf.2016.03.008.
Shaghaghi, M., Soleyman-jahi, S., Abolhassani, H., Yazdani, R., Azizi, G., & Rezaei, N. (2018). New Insights Into Physiopathology of Immunodeficiency-Associated Vaccine-Derived Poliovirus Infection; Systematic Review of Over 5 Decades of Data. Vaccine, 36, 1711-1719. DOI: 10.1016/j.vaccine.2018.02.059.
Cervia, C., Nilsson, J., Zurbuchen, Y., Valaperti, A., Schreiner, J., Wolfensberger, A., … Boyman, O. (2021). Systemic and mucosal antibody responses specific to SARS-CoV-2 during mild versus severe COVID-19. J. Allergy Clin. Immunol., 147(2), 545-557.e9.
DOI: 10.1016/j.jaci.2020.10.040.
Li, D., Calderone, R., Nsouli, T.M., Reznikov, E., & Bellanti, J.A. (2022). Salivary and serum IgA and IgG responses to SARS-CoV-2-spike protein following SARS-CoV-2 infection and after immunization with COVID-19 vaccines. Allergy Asthma Proc., 1, 43(5), 419-430.
DOI: 10.2500/aap.2022.43.220045.
Lamm, M.E. (1988). The IgA mucosal immune system. Am. J. Kidney Dis., 12(5), 384-387.
DOI: 10.1016/s0272-6386(88)80030-1.
Williams, E., Bond, K., Zhang, B., Putland, M, & Williamson, D.A. (2020). Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2. J. Clin. Microbiol., 23, 58(8), e00776-20. DOI: 10.1128/JCM.00776-20.
(2020). Sample collection and stabilization from saliva samples for SARS-CoV-2 detection by qPCR. Biotechniques., 69(3), 237. DOI: 10.2144/btn-2020-1001ap.
Hou, H., Chen J., Wang, Y., Lu, Y., Zhu, Y., Zhang, B., … Sun, Z. (2020). Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens. J. Clin. Microbiol., 23, 58(8), e01288-20. DOI: 10.1128/JCM.01288-20.
McCormick-Baw, C., Morgan, K., Gaffney, D., Cazares, Y., Jaworski, K., Byrd, A., Molberg, K., & Cavuoti, D. (2020). Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2. J. Clin. Microbiol., 23, 58(8), e01109-20. DOI: 10.1128/JCM.01109-20.
Xu, H., Zhong, L., Deng, J., & Peng, J. (2020). High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral. Sci., 12(1), 1-5.
DOI: 10.1038/s41368-020-0074-x.
Wudan, Y. (2020). Their Teeth Fell Out. Was It Another Covid-19 Consequence? The New York Times (en-US). ISSN 0362-4331. Retrieved from: https://www.summitdentalclinic.org/blog/loose-teeth.
Levison, M.E. (2020). Commentary: What we know so far about post-COVID syndrome. Merck Manual Professional Version. Retrieved from: https://www.merckmanuals.com/professional/news/editorial/2020/09/23/20/17/post-covid-syndrome.
COVID-19 (coronavirus): Long-term effects. Mayo Clinic. Retrieved from: https://www.mayoclinic.org/diseases-conditions/coronavirus/in-depth/coronavirus-long-term-effects/art-20490351.
Grammatikos, A., Donati, M., Johnston, S.L., & Gompels, M.M. (2021). Peripheral B Cell Deficiency and Predisposition to Viral Infections: The Paradigm of Immune Deficiencies. Front. Immunol., 30, 12, 731643.
DOI: 10.3389/fimmu.2021.731643.
Kryukova, N., Baranova, I., Abramova, N., Khromova, E., Pachomov, D., Svitich, O., Chuchalin, A., & Kostinov, M. (2023). Mucosal immunity in health care workers' respiratory tracts in the post-COVID-19 period. Sci. Rep., 13(1), 7162. DOI: 10.1038/s41598-023-32670-w.
Gemelli Against COVID-19 Post-Acute Care Study Group Post-COVID-19 Global health care strategies: the need for an interdisciplinary approach (2020). Aging Clin. Exp. Res. DOI: 10.1007/s40520-020-01616-x.
Callard, F., & Perego, E., (2021). How and Why Patients Made Long Covid. Soc. Sci. Med., 268, 113426.
DOI: 10.1016/j.socscimed.2020.113426.
National Institute for Health Research (2020). Living with COVID-19: A dynamic review of the evidence around ongoing COVID-19 symptoms (often called long COVID). Retrieved from: https://evidence.nihr.ac.uk/themedreview/living-with-covid19.
Post-COVID conditions: Information for healthcare providers. Centers for Disease Control and Prevention (2021). Retrieved from: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covid-conditions.html.
Rayner, C., Lokugamage, A.U., & Molokhia M. (2020). COVID-19: a prolonged and relapsing course of illness has implications for returning workers. Retrieved from: https://blogs.bmj.com/bmj/2020/06/23/covid-19-prolonged-and-relapsing-course-of-illness-has-implications-for-returning-workers/.
Siddiqi, H.K., & Mehra, M.R. (2020). COVID-19 illness in native and immunosuppressed states: A clinical-therapeutic staging proposal. J. Heart Lung Transplant., 39(5), 405-407. DOI: 10.1016/j.healun.2020.03.012.
Karakike, E., & Giamarellos-Bourboulis, E.J. (2019). Macrophage Activation-Like Syndrome: A Distinct Entity Leading to Early Death in Sepsis. Front. Immunol., 31, 10, 55. DOI: 10.3389/fimmu.2019.00055.
Coomes, E.A., & Haghbayan, H. (2020). Interleukin-6 in Covid-19: A systematic review and meta-analysis. Rev. Med. Virol., 30(6), 1-9. DOI: 10.1002/rmv.2141.
Copaescu, A., Smibert, O., Gibson, A., Phillips, E.J., & Trubiano, J.A. (2020). The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection. J. Allergy Clin. Immunol., 146(3), 518-534.e1. DOI: 10.1016/j.jaci.2020.07.001.
Chukwuma, I.F., Apeh, V.O., & Chiletugo, O.F. (2021). Mechanisms and potential therapeutic targets of hyperinflammatory responses in SARS-CoV-2. Acta Virol., 65(1), 3-9. DOI: 10.4149/av_2021_102.
England, J.T., Abdulla, A., Biggs, C.M., Lee, A.Y.Y., Hay, K.A., Hoiland, R.L., … Chen, L.Y.C. (2021). Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes. Blood Rev., 45, 100707.
DOI: 10.1016/j.blre.2020.100707.
Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P., & Hejblum, G. (2014). Development and validation of the HScore, a score for the diagnosis of reactive hemophagocytic syndrome. Arthritis Rheumatol., 66(9), 2613-2620.
DOI: 10.1002/art.38690.
Mehta, P., McAuley, D.F., & Brown, M. (2020). COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet, 395, 1033-1034.
DOI: 10.1016/S0140-6736(20)30628-0.
Kim, G., Wang, M., Pan, H. Davidson, G., Roxby, A.C., Neukirch, J., Lei, D., Hawken-Dennis, E., Simpson, L., & Ong, D.T. (2020). A health system response to COVID-19 in long term care and post-acutecare: a three-phase approach. J. Am. Geriatr. Soc., 68(6), 1155-1161.
DOI: 10.1111/jgs.16513.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 CLINICAL DENTISTRY
This work is licensed under a Creative Commons Attribution 4.0 International License.
